Search by Drug Name or NDC

    NDC 61874-0115-17 Vraylar 1.5 mg/1 Details

    Vraylar 1.5 mg/1

    Vraylar is a ORAL CAPSULE, GELATIN COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Allergan, Inc.. The primary component is CARIPRAZINE.

    Product Information

    NDC 61874-0115
    Product ID 61874-115_e342dd19-ed3b-4a30-b5ea-a17b3638e741
    Associated GPIs 59400018100120
    GCN Sequence Number 074807
    GCN Sequence Number Description cariprazine HCl CAPSULE 1.5 MG ORAL
    HIC3 H8W
    HIC3 Description ANTIPSYCHOTIC-ATYPICAL,D3/D2 PARTIAL AG-5HT MIXED
    GCN 39579
    HICL Sequence Number 042552
    HICL Sequence Number Description CARIPRAZINE HCL
    Brand/Generic Brand
    Proprietary Name Vraylar
    Proprietary Name Suffix n/a
    Non-Proprietary Name cariprazine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE, GELATIN COATED
    Route ORAL
    Active Ingredient Strength 1.5
    Active Ingredient Units mg/1
    Substance Name CARIPRAZINE
    Labeler Name Allergan, Inc.
    Pharmaceutical Class Atypical Antipsychotic [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA204370
    Listing Certified Through 2024-12-31

    Package

    NDC 61874-0115-17 (61874011517)

    NDC Package Code 61874-115-17
    Billing NDC 61874011517
    Package 1 BLISTER PACK in 1 CARTON (61874-115-17) / 7 CAPSULE, GELATIN COATED in 1 BLISTER PACK
    Marketing Start Date 2016-03-01
    NDC Exclude Flag N
    Pricing Information N/A